BACKGROUND: Avidity of antiphospholipid antibodies may be clinically useful as a valuable additional characteristic. The aim of this study was to compare several ELISA modifications with different chaotropic agents and calculation of avidity indices for the determination of anticardiolipin antibody (aCL) avidity. METHODS: We examined 28 serum samples with positive IgG aCL by adapted ELISA using various concentrations of urea and sodium chloride as chaotropic agents and different dilution of sera. We tested these conditions of ELISA-a single diluted serum sample with fixed concentration of a chaotrope and a serially diluted serum in the constant concentration of a chaotropic agent. RESULTS: We demonstrated that ELISA method for avidity determination based on a single dilution of serum in the presence of fixed concentration of chaotrope is convenient for determination of IgG aCL antibody avidity. Concentrations 6 and 8 mol/L of urea or 1 and 2 mol/L of NaCl were suitable for sufficient dissociation of immune complexes during ELISA procedure. CONCLUSION: This way was in good agreement with more demanding procedures. Both urea and sodium chloride may be used as chaotropic agents. Reference values of avidity indices essential for interpretation of patients' results must be established individually for distinct assay conditions.

Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Zobrazit více v PubMed

Ke K, Strango ZI, Harper PE, Zhao M. Influence of phosphatidylethanolamine concentration and composition on the detection of antiphosphatidylethanolamine antibodies by ELISA. J Clin Lab Anal. 2016;30:689–696. PubMed PMC

Krilis SA, Giannakopoulos B. Laboratory methods to detect antiphospholipid antibodies. Hematology Am Soc Hematol Educ Program. 2014;2014:321–328. PubMed

Pengo V, Denas G, Banzato A, et al. Interpretation of laboratory data and need for reference laboratories. Lupus. 2012;21:732–733. PubMed

Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306. PubMed

Hughes GR, Shoenfeld Y. Antiphospholipid antibody testing ‐ slow progress? Int J Clin Pract. 2012;66:533–535. PubMed

Artenjak A, Lakota K, Frank M, et al. Antiphospholipid antibodies as non‐traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review. Autoimmun Rev. 2012;11:873–882. PubMed

Mankai A, Manoubi W, Ghozzi M, Melayah S, Sakly W, Ghedira I. High frequency of antiphospholipid antibodies in primary biliary cirrhosis. J Clin Lab Anal. 2015;29:32–36. PubMed PMC

Božič B, Čučnik S, Kveder T, Rozman B. Affinity and avidity of autoantibodies In: Shoenfeld Y, Gershwin ME, Meroni PL, eds. Autoantibodies. Amsterdam: Elsevier; 2007: 21–28.

Fialova L. Avidity of antiphospholipid antibodies ‐ our current knowledge. Epidemiol Mikrobiol Imunol. 2014;63:221–225. PubMed

Bozic B, Cucnik S, Kveder T, Rozman B. Avidity of anti‐beta‐2‐glycoprotein I antibodies. Autoimmun Rev. 2005;4:303–308. PubMed

Cucnik S, Bozic B, Kveder T, Tomsic M, Rozman B. Avidity of anti‐beta2‐glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome. Ann N Y Acad Sci. 2005;1051:141–147. PubMed

Cucnik S, Kveder T, Artenjak A, et al. Avidity of anti‐beta2‐glycoprotein I antibodies in patients with antiphospholipid syndrome. Lupus. 2012;21:764–765. PubMed

Zachou K, Liaskos C, Rigopoulou E, et al. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol. 2006;119:203–212. PubMed

Liaskos C, Rigopoulou E, Zachou K, et al. Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun. 2005;24:251–260. PubMed

Lynch HE, Stewart SM, Kepler TB, Sempowski GD, Alam SM. Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen. J Immunol Methods. 2014;404:1–12. PubMed PMC

Dimitrov JD, Lacroix‐Desmazes S, Kaveri SV. Important parameters for evaluation of antibody avidity by immunosorbent assay. Anal Biochem. 2011;418:149–151. PubMed

Cucnik S, Kveder T, Ulcova‐Gallova Z, et al. The avidity of anti‐beta2‐glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies. Lupus. 2011;20:1166–1171. PubMed

Dauner JG, Pan Y, Hildesheim A, Kemp TJ, Porras C, Pinto LA. Development and application of a GuHCl‐modified ELISA to measure the avidity of anti‐HPV L1 VLP antibodies in vaccinated individuals. Mol Cell Probes. 2012;26:73–80. PubMed PMC

Almanzar G, Ottensmeier B, Liese J, Prelog M. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme‐linked immunosorbent assay (ELISA) using ammonium thiocyanate. J Immunol Methods. 2013;387:36–42. PubMed

Vlachoyiannopoulos PG, Petrovas C, Tektonidou M, Krilis S, Moutsopoulos HM. Antibodies to beta 2‐glycoprotein‐I: urea resistance, binding specificity, and association with thrombosis. J Clin Immunol. 1998;18:380–391. PubMed

Perciani CT, Peixoto PS, Dias WO, Kubrusly FS, Tanizaki MM. Improved method to calculate the antibody avidity index. J Clin Lab Anal. 2007;21:201–206. PubMed PMC

Jenum PA, Stray‐Pedersen B, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol. 1997;35:1972–1977. PubMed PMC

Polanec J, Seppälä I, Rousseau S, Hedman K. Evaluation of protein‐denaturing immunoassays for avidity of immunoglobulin G to rubella virus. J Clin Lab Anal. 1994;8:16–21. PubMed

Fialova L, Malbohan I, Malickova K. Avidity of anticardiolipin antibodies‐A factor that could be important for their detection by ELISA methods. J Appl Biomed. 2014;12:277–284.

Pierangeli SS, Harris EN. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc. 2008;3:840–848. PubMed

Lakos G, Favaloro EJ, Harris EN, et al. International consensus guidelines on anticardiolipin and anti‐beta2‐glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum. 2012;64:1–10. PubMed

Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135–160. PubMed

Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods. 1986;86:83–87. PubMed

Hedman K, Lappalainen M, Seppaia I, Makela O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis. 1989;159:736–740. PubMed

Prince HE, Wilson M. Simplified assay for measuring Toxoplasma gondii immunoglobulin G avidity. Clin Diagn Lab Immunol. 2001;8:904–908. PubMed PMC

Avidity of anti-phospholipid antibodies in relation to their levels